SIGA Technologies
SIGA
$8.23
Share price
-3.29%
Change (1 day)
36.48%
Change (1 year)
Categories
Operating Margin for SIGA Technologies (SIGA)
Operating Margin as of April 2024 (TTM): 66.81%
According to SIGA Technologies's latest financial reports and stock price the company's current Operating Margin is 66.81%. At the end of 2021 the company had an Operating Margin of 66.81%.
Operating Margin history for SIGA Technologies from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 66.81% | 13.58% |
| 2020 | 58.83% | -254.56% |
| 2019 | -38.06% | -144.11% |
| 2018 | 86.29% | -127.62% |
| 2017 | -312.41% | 17.99% |
| 2016 | -264.78% | -44.48% |
| 2015 | -476.88% | -92.93% |
| 2014 | -6,749.87% | 1402.46% |
| 2013 | -449.26% | 80.14% |
| 2012 | -249.39% | 41.45% |
| 2011 | -176.31% | 166.31% |
| 2010 | -66.21% | -23.02% |
| 2009 | -86.01% | -20.6% |
| 2008 | -108.32% | -2.77% |
| 2007 | -111.41% | 18.73% |
| 2006 | -93.84% | 214.12% |
| 2005 | -29.87% | -93.81% |
| 2004 | -482.82% | -33.28% |
| 2003 | -723.60% | -25.93% |
| 2002 | -976.95% | 247.28% |
| 2001 | -281.31% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | -88.19% | -232.00% | 🇺🇸 USA |
 Novavax NVAX | -149.57% | -323.87% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -1,520.92% | -2,376.49% | 🇺🇸 USA |
 NanoViricides NNVC | 0.00% | N/A | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | -77.02% | -215.28% | 🇺🇸 USA |
 Emergent BioSolutions
EBS | 17.53% | -73.76% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.